新辅助免疫疗法在早期,三阴性乳腺癌:赶上其余的
Leah Kim1, Magdalena Coman1, Lajos Pusztai2
1Section of Surgical Oncology, Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
Annals of surgical oncology
|June 22, 2023
概括
免疫检查点抑制剂与化疗相结合,在早期三阴性乳腺癌 (TNBC) 中显示出有前途. 未来的研究将集中在缓解辅助疗法和探索新的生物标志物,如微生物群.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 在历史上,三阴性乳腺癌 (TNBC) 被认为是"免疫学冷".
- 最近的进展涉及免疫检查点调制与早期TNBC的新辅助化疗相结合.
- 这种方法在临床试验中取得了令人兴奋的进展.
研究的目的:
- 审查新辅助免疫化学疗法在TNBC早期的主要临床试验.
- 分析这些试验的病理完整反应率和生存数据.
- 讨论TNBC治疗的未来挑战和机遇.
主要方法:
- 对主要临床试验的审查,这些试验研究了TNBC新辅助剂的组合免疫化学疗法.
- 分析病理完整反应 (pCR) 率.
- 评估无事件生存率 (EFS) 和整体生存率 (OS) 数据.
主要成果:
- 组合免疫化学疗法在TNBC早期已经显示出有希望的病理完整反应率.
- 关于无事件和整体存活的成熟数据正在变得可用.
- 确定的挑战包括降低辅助治疗的升级和改善残留疾病患者的治疗结果.
结论:
- 新辅助免疫化学疗法代表了早期TNBC的显著进展.
- 未来的方向包括提炼生物标志物 (PD-L1,TILs,TMB) 和探索基于微生物组的疗法等新方法.
- 优化辅助治疗策略对于改善TNBC的长期结果至关重要.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.2K
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cancer Vaccines
433
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
